GRASSILLI, EMANUELA
GRASSILLI, EMANUELA
DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer
2024 Ilari, A; Cogliati, V; Sherif, N; Grassilli, E; Ramazzotti, D; Cordani, N; Cazzaniga, G; Di Bella, C; Lavitrano, M; Cazzaniga, M; Cerrito, M
"Ironing out" fasting-induced persister cancer cells to render chemotherapy effective: is this the solution?
2023 Grassilli, E; Cerrito, M
BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression
2023 Betzler, A; Strobel, H; Abou Kors, T; Ezić, J; Lesakova, K; Pscheid, R; Azoitei, N; Sporleder, J; Staufenberg, A; Drees, R; Weissinger, S; Greve, J; Doescher, J; Theodoraki, M; Schuler, P; Laban, S; Kibe, T; Kishida, M; Kishida, S; Idel, C; Hoffmann, T; Lavitrano, M; Grassilli, E; Brunner, C
Targeting p65BTK for treating solid cancers
2023 Grassilli, E; Cerrito, M; Bonomo, S; Giovannoni, R; Conconi, D; and Lavitrano, M
BTK, the new kid on the (oncology) block?
2022 Grassilli, E; Cerrito, M; Lavitrano, M
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation
2022 Scagliotti, A; Capizzi, L; Cazzaniga, M; Ilari, A; De Giorgi, M; Cordani, N; Gallazzi, M; Bruno, A; Pelosi, G; Albini, A; Lavitrano, M; Grassilli, E; Cerrito, M
Editorial: Targeting Bruton Tyrosine Kinase
2022 Brunner, C; Betzler, A; Brown, J; Andreotti, A; Grassilli, E
Emerging actionable targets to treat therapy-resistant colorectal cancers
2022 Grassilli, E; Cerrito, M
Identifying novel actionable targets in colon cancer
2021 Cerrito, M; Grassilli, E
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors
2021 Grassilli, E; Cerrito, M; Bonomo, S; Giovannoni, R; Conconi, D; Lavitrano, M
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers
2020 Lavitrano, M; Ianzano, L; Bonomo, S; Cialdella, A; Cerrito, M; Pisano, F; Missaglia, C; Giovannoni, R; Romano, G; Mclean, C; Voest, E; D'Amato, F; Noli, B; Ferri, G; Agostini, M; Pucciarelli, S; Helin, K; Leone, B; Canzonieri, V; Grassilli, E
The antiangiogenic effect of the metronomic combination of 5-Fluorouracil plus vinorelbine is mediated by FAK/AKT pathway downregulation and apoptosis activation
2020 Scagliotti, A; Grassilli, E; Cazzaniga, M; Capizzi, L; Lavitrano, M; Cerrito, M
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma
2019 Giordano, F; Vaira, V; Cortinovis, D; Bonomo, S; Goedmakers, J; Brena, F; Cialdella, A; Ianzano, L; Forno, I; Cerrito, M; Giovannoni, R; Ferri, G; Tasciotti, E; Vicent, S; Damarco, F; Bosari, S; Lavitrano, M; Grassilli, E
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer
2019 Basile, D; Gerratana, L; Buonadonna, A; Garattini, S; Perin, T; Grassilli, E; Miolo, G; Cerrito, M; Belluco, C; Bertola, G; De Paoli, A; Cannizzaro, R; Lavitrano, M; Puglisi, F; Canzonieri, V
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype
2019 Sala, L; Cirillo, G; Riva, G; Romano, G; Giussani, C; Cialdella, A; Todisco, A; Virtuoso, A; Cerrito, M; Bentivegna, A; Grassilli, E; Ardizzoia, A; Bonoldi, E; Giovannoni, R; Papa, M; Lavitrano, M
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study.
2018 Cerrito, M; De Giorgi, M; Pelizzoni, D; Bonomo, S; Digiacomo, N; Scagliotti, A; Bugarin, C; Gaipa, G; Grassilli, E; Lavitrano, M; Giovannoni, R; Bidoli, P; Cazzaniga, M
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro
2017 Chisci, E; De Giorgi, M; Zanfrini, E; Testasecca, A; Brambilla, E; Cinti, A; Farina, L; Kutryb Zając, B; Bugarin, C; Villa, C; Grassilli, E; Combi, R; Gaipa, G; Cerrito, M; Rivolta, I; Smolenski, R; Lavitrano, M; Giovannoni, R
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation
2016 Grassilli, E; Pisano, F; Cialdella, A; Bonomo, S; Missaglia, C; Cerrito, M; Masiero, L; Ianzano, L; Giordano, F; Cicirelli, V; Narloch, R; D’Amato, F; Noli, B; Ferri, G; Leone, B; Stanta, G; Bonin, S; Helin, K; Giovannoni, R; Lavitrano, M
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells
2016 Romano, G; Santi, L; Bianco, M; Giuffrè, M; Pettinato, M; Bugarin, C; Garanzini, C; Savarese, L; Leoni, S; Cerrito, M; Leone, B; Gaipa, G; Grassilli, E; Papa, M; Lavitrano, M; Giovannoni, R
Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients
2016 Conconi, D; Redaelli, S; Bovo, G; Leone, B; Filippi, E; Ambrosiani, L; Cerrito, M; Grassilli, E; Giovannoni, R; Dalpra', L; Lavitrano, M